GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GHRS is expected to report earnings to rise 11.84% to -21 cents per share on August 20
Q2'25
Est.
$-0.21
Q1'25
Beat
by $0.16
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.02
The last earnings report on May 08 showed earnings per share of -18 cents, beating the estimate of -34 cents. With 112.72K shares outstanding, the current market capitalization sits at 744.34M.